Journal of Clinical and Translational Medicine (MEDIXIS) is a peer-reviewed, open-access scientific journal published by PT Litera Integra Nusantara. The journal provides an international platform for the dissemination of high-quality original research articles, review papers, and clinical studies that advance clinical medicine, translational medicine, biomedical sciences, and healthcare innovation. MEDIXIS aims to bridge fundamental biomedical discoveries with clinical applications to improve patient diagnosis, treatment, prevention, rehabilitation, and overall healthcare outcomes through evidence-based medical research. The journal welcomes original research articles, review papers, systematic reviews, meta-analyses, short communications, and clinical studies in, but not limited to, clinical medicine, internal medicine, surgery, pediatrics, obstetrics and gynecology, cardiology, pulmonology, neurology, psychiatry, emergency medicine, critical care, translational medicine, molecular medicine, genetics and genomics, immunology, pathology, precision medicine, personalized medicine, biomarkers, clinical pharmacology, pharmacotherapy, clinical trials, laboratory medicine, medical imaging, diagnostic technologies, medical devices, clinical nutrition, rehabilitation medicine, lifestyle medicine, patient safety, healthcare quality, evidence-based medicine, artificial intelligence in clinical practice, digital health, telemedicine, emerging infectious diseases, non-communicable diseases (NCDs), and other emerging topics in clinical and translational medicine. The journal is published in electronic (online) format with a frequency of three issues per year, released in April, August, and December. The inaugural issue is scheduled for publication in August 2026. All submitted manuscripts undergo a rigorous peer-review process to ensure scientific quality, originality, ethical integrity, and scientific relevance.